Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pontus Eriksson

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|October 15, 2019
Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinomaGottfrid Sjödahl, Pontus Eriksson, Oliver Patschan, et al.
The American Journal of Pathology|July 6, 2013
Toward a molecular pathologic classification of urothelial carcinomaGottfrid Sjödahl, Kristina Lövgren, Martin Lauss, et al.
European Urology|March 16, 2015
A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial CarcinomaOliver Patschan, Gottfrid Sjödahl, Gunilla Chebil, et al.
The Journal of Pathology|July 26, 2018
FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammationMona Foth, Nur Faezah Binti Ismail, Jeng Sum Charmaine Kung, et al.
Biochemical and Biophysical Research Communications|March 27, 2018
Promoter-associated proteins of EPAS1 identified by enChIP-MS - A putative role of HDX as a negative regulatorArash Hamidian, Marica Vaapil, Kristoffer von Stedingk, et al.
Experimental Hematology & Oncology|July 3, 2025
Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastasesCarina Bernardo, Subhayan Chattopadhyay, Natalie Andersson, et al.
Cells|June 19, 2024
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular SubtypesViktor Sincic, Ken F Arlenhold, Sarah Richtmann, et al.
European Urology|November 16, 2021
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular SubtypesGottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al.
NPJ Precision Oncology|July 3, 2026
Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent mannerAymeric Zadoroznyj, Pontus Eriksson, Carina Bernardo, et al.
Bladder Cancer (Amsterdam, Netherlands)|May 27, 2026
Proceedings of the first international NMIBC consensus classification meetingJoep J de Jong, Ane Moreno-Oya, Mitchell Olislagers, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|October 15, 2019
Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinomaGottfrid Sjödahl, Pontus Eriksson, Oliver Patschan, et al.
The American Journal of Pathology|July 6, 2013
Toward a molecular pathologic classification of urothelial carcinomaGottfrid Sjödahl, Kristina Lövgren, Martin Lauss, et al.
European Urology|March 16, 2015
A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial CarcinomaOliver Patschan, Gottfrid Sjödahl, Gunilla Chebil, et al.
The Journal of Pathology|July 26, 2018
FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammationMona Foth, Nur Faezah Binti Ismail, Jeng Sum Charmaine Kung, et al.
Biochemical and Biophysical Research Communications|March 27, 2018
Promoter-associated proteins of EPAS1 identified by enChIP-MS - A putative role of HDX as a negative regulatorArash Hamidian, Marica Vaapil, Kristoffer von Stedingk, et al.
Experimental Hematology & Oncology|July 3, 2025
Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastasesCarina Bernardo, Subhayan Chattopadhyay, Natalie Andersson, et al.
Cells|June 19, 2024
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular SubtypesViktor Sincic, Ken F Arlenhold, Sarah Richtmann, et al.
European Urology|November 16, 2021
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular SubtypesGottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al.
NPJ Precision Oncology|July 3, 2026
Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent mannerAymeric Zadoroznyj, Pontus Eriksson, Carina Bernardo, et al.
Bladder Cancer (Amsterdam, Netherlands)|May 27, 2026
Proceedings of the first international NMIBC consensus classification meetingJoep J de Jong, Ane Moreno-Oya, Mitchell Olislagers, et al.
Pageof 5